Cocoa flavanols and brain perfusion

Journal of Cardiovascular Pharmacology

Volumn 47, Issue SUPPL. 2, 2006, Pages

  Fisher, Naomi D L ^a   Sorond, Farzaneh A ^b   Hollenberg, Norman K ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Brain perfusion; Cocoa; Flavanols; MRI; Transcranial Doppler

Indexed keywords

FLAVANOL DERIVATIVE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE;

ADULT; AGED; ARTICLE; BRAIN BLOOD FLOW; BRAIN PERFUSION; CACAO; ENDOTHELIUM; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; VASODILATATION;

AGED; AGING; BEVERAGES; CACAO; CEREBROVASCULAR CIRCULATION; DEMENTIA, VASCULAR; ENDOTHELIUM, VASCULAR; FLAVONOIDS; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; VASODILATION;

EID: 33750357163     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200606001-00017     Document Type: Article

References (32)

1. Vita JA. Polyphenols and cardiovascular disease: effects on endothelial and platelet function. Am J Clin Nutr. 2005;81:292S-297S.
2. Engelhart MJ, Geerlings MI, Ruitenberg A, et al. Dietary intake of antioxidants and risk of Alzheimer disease. JAMA. 2002;287:3223-3229.
3. Commenges D, Scotet V, Renaud S, et al. Intake of flavonoids and risk of dementia. Eur J Epidemiol. 2000;16:357-363.
4. Hollenberg NK, Martinez G, McCullough M, et al. Aging, acculturation, salt intake, and hypertension in the Kuna of Panama. Hypertension. 1997;29:171-176.
5. Karim M, McCormick K, Kappagoda CT. Effects of cocoa extracts on endothelium-dependent relaxation. J Nutr. 2000;130:2105S-2108S.
6. Diebolt M, Bucher B, Andriantsitohaina R. Wine polyphenols decrease blood pressure, improve NO vasodilatation, and induce gene expression. Hypertension. 2001;38:159-165.
7. Leikert JF, Rathel TR, Wohlfart P, et al. Red wine polyphenols enhance endothelial nitric oxide synthase expression and subsequent nitric oxide release from endothelial cells. Circulation. 2002;106:1614-1617.
8. Fitzpatrick DF, Hirschfield SL, Ricci T, et al. Endothelium-dependent vasorelaxation caused by various plant extracts. J Cardiovasc Pharmacol. 1995;26:90-95.
9. Andriambeloson E, Kleschyov AL, Muller B, et al. Nitric oxide production and endothelium-dependent vasorelaxation induced by wine polyphenols in rat aorta. Br J Pharmacol. 1997;120:1053-1058.
10. Cishek MB, Galloway MT, Karim M, et al. Effect of red wine on endothelium-dependent relaxation in rabbits. Clin Sci (London). 1997;93:507-511.
11. Fisher ND, Hughes M, Gerhard-Herman M, et al. Flavanol-rich cocoa induces nitric-oxide-dependent vasodilation in healthy humans. J Hypertens. 2003;21:2281-2286.
12. Perticone F, Ceravolo R, Pujia A, et al. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation. 2001;104:191-196.
13. Engler MB, Engler MM, Chen CY, et al. Flavonoid-rich dark chocolate improves endothelial function and increases plasma epicatechin concentrations in healthy adults. J Am Coll Nutr. 2004;23:197-204.
14. Vlachopoulos C, Aznaouridis K, Alexopoulos N, et al. Effect of dark chocolate on arterial function in healthy individuals. Am J Hypertens. 2005;18:785-791.
15. Heiss C, Dejam A, Kleinbongard P, et al. Vascular effects of cocoa rich in flavan-3-ols. JAMA. 2003;290:1030-1031.
16. Grassi D, Necozione S, Lippi C, et al. Cocoa reduces blood pressure and insulin resistance and improves endothelium-dependent vasodilation in hypertensives. Hypertension. 2005;46:398-405.
17. Vapaatalo H, Mervaala E. Clinically important factors influencing endothelial function. Med Sci Monit. 2001;7:1075-1085.
18. Brunner H, Cockcroft JR, Deanfield J, et al. Endothelial function and dysfunction. Part II: association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension. J Hypertens. 2005;23:233-246.
19. Shi J, Perry G, Smith MA, et al. Vascular abnormalities: the insidious pathogenesis of Alzheimer's disease. Neurobiol Aging. 2000;21:357-361.
20. Fratiglioni L. Epidemiology. In: Winbald B, et al. ed. Health Economics of Dementia. New York: John Wiley & Sons.
21. Konno S, Meyer JS, Terayama Y, et al. Classification, diagnosis and treatment of vascular dementia. Drugs Aging. 1997;11:361-373.
22. Breteler MM. Vascular risk factors for Alzheimer's disease: an epidemiologic perspective. Neurobiol Aging. 2000;21:153-160.
23. Meyer JS, Rauch GM, Rauch RA, et al. Cardiovascular and other risk factors for Alzheimer's disease and vascular dementia. Ann NY Acad Sci. 2000;903:411-423.
24. Kokmen E, Whisnant JP, O'Fallon WM, et al. Dementia after ischemic stroke: a population-based study in Rochester, Minnesota (1960-1984). Neurology. 1996;46:154-159.
25. Kalaria RN. The role of cerebral ischemia in Alzheimer's disease. Neurobiol Aging. 2000;21:321-330.
26. Kalaria RN, Ballard C. Overlap between pathology of Alzheimer disease and vascular dementia. Alzheimer Dis Assoc Disord. 1999;13(Suppl 3):S115-S123.
27. Grammas P. A damaged microcirculation contributes to neuronal cell death in Alzheimer's disease. Neurobiol Aging. 2000;21:199-205.
28. Youdim KA, Spencer JP, Schroeter H, et al. Dietary flavonoids as potential neuroprotectants. Biol Chem. 2002;383:503-519.
29. Galli RL, Shukitt-Hale B, Youdim KA, et al. Fruit polyphenolics and brain aging: nutritional interventions targeting age-related neuronal and behavioral deficits. Ann NY Acad Sci. 2002;959:128-132.
30. Ruitenberg A, den Heijer T, Bakker SL, et al. Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study. Ann Neurol. 2005;57:789-794.
31. Nagahama Y, Nabatame H, Okina T, et al. Cerebral correlates of the progression rate of the cognitive decline in probable Alzheimer's disease. Eur Neurol. 2003;50:1-9.
32. Johnson KA, Jones K, Holman BL, et al. Preclinical prediction of Alzheimer's disease using SPECT. Neurology. 1998;50:1563-1571.